Literature DB >> 24411996

Self-reports of consumption of amphetamines, cocaine and heroin in a survey among marginalized drug users.

Ellen J Amundsen1, Malcolm J Reid2.   

Abstract

BACKGROUND AND AIM: Scientific literature offers few measurements of the quantities consumed by individual drug users. Such measurements are used for calculating the total drug consumption by the quantity-frequency method, and are extremely important for the comparison with waste water derived consumption estimates. The aim of this study was to measure quantities of amphetamines, cocaine and heroin consumed by marginalized drug users, using a multi-city questionnaire survey design. Variation by gender, age, frequency of use, main drug used and city was explored.
RESULTS: The self-reported quantity used on the last day of use was for amphetamines on average 800 mg, for cocaine 1,014 mg and for heroin 682 mg. The self-reported usual dose was on average 297 mg, 487 mg and 297 mg respectively, while the median value was 250 mg for all three drugs. Overall, gender and age group were less important than frequency of use and the main drug used for establishing differences regarding the outcome variables. There were some differences regarding cities. No measure of purity was carried out at the interview sites, so the calculation of pure quantities was based on aggregate results from analyses of seizures by police and customs.
CONCLUSIONS: The self-reported quantities of drugs consumed in three cities in Norway was equal to or somewhat higher among marginalized users than earlier assumed, where assumptions were based on limited literature and anecdotal information.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amphetamines; Cocaine; Dose; Heroin; Quantity; Self-reported

Mesh:

Substances:

Year:  2014        PMID: 24411996     DOI: 10.1016/j.scitotenv.2013.12.098

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  1 in total

1.  The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats.

Authors:  Paul R Pentel; Michael D Raleigh; Mark G LeSage; Thomas Thisted; Stephen Horrigan; Zuzana Biesova; Matthew W Kalnik
Journal:  BMC Biotechnol       Date:  2018-07-24       Impact factor: 2.563

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.